CLINICAL_TRIALS
trial_result
· 2023-04-24
Clinical Trial Update: Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy [Phase 2, Phase 3]
Summary
Phase 2/3 trial update on ketamine for severe adolescent major depressive disorder; study terminated with posted results in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yale University | Conditions: Major Depressive Disorder | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2023-04-24